CAR T Cell Therapy
CAR T Cell Therapy
What is CAR-T Cell Therapy?
CAR-T (Chimeric Antigen Receptor T-cell) Therapy is a revolutionary form of immunotherapy that reprograms a patient’s own immune cells to recognize and attack cancer cells. This personalized treatment has shown remarkable success in treating certain types of blood cancers, including leukemia and lymphoma, especially in patients who have not responded to conventional therapies.
How Does CAR-T Cell Therapy Work?
In this therapy, T-cells are extracted from the patient’s blood and genetically modified in a laboratory to produce special receptors called CARs that can identify cancer cells. These engineered cells are then multiplied and infused back into the patient’s body, where they seek out and destroy cancer cells.
Who Can Benefit from CAR-T Cell Therapy?
- Patients with relapsed or refractory leukemia
- Certain types of lymphoma
- Some patients with multiple myeloma (depending on eligibility and clinical trials)
Advantages of CAR-T Cell Therapy
- Highly personalized treatment targeting cancer cells directly
- Potential for long-lasting remission even in difficult cases
- Option when other treatments have failed
CAR-T Cell Therapy in India
India offers access to CAR-T therapy through leading cancer hospitals equipped with cutting-edge technology and expert teams. Treatment costs in India are typically more affordable compared to Western countries, making this innovative therapy accessible to a wider range of patients. Additionally, India’s comprehensive patient support services help international patients with treatment planning, travel, and post-therapy care.
Interested in CAR-T Cell Therapy?
Send us your medical reports via Viber or WhatsApp, or fill out the contact form with your details and preferred contact number. Our 4R Consultancy team will evaluate your case and connect you with expert oncologists in India for personalized treatment planning.
